SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Lukas Biewald was appointed to the Board of Directors effective May 20, 2026, and concurrently appointed to the Nominating and Corporate Governance Committee. The appointment includes compensatory arrangements consisting of RSU awards and cash retainers.
View raw filing on EDGAR →Amit Muni was appointed as Executive Vice President and Chief Financial Officer effective June 8, 2026, succeeding Michael Donohue. The appointment includes compensatory terms including a base salary of $450,000, guaranteed bonuses, and RSU awards.
View raw filing on EDGAR →The filing discloses the appointment of Michael Weinbach as CEO-Elect effective June 1, 2026, and subsequently as Chief Executive Officer and Board member effective August 13, 2026, succeeding retiring CEO Richard G. Thornberry. While the section also covers compensatory arrangements (base salary of $1,000,000, STI target of $1,166,666, and LTI awards totaling $6,000,000 plus sign-on equity), the principal disclosed action is Weinbach's appointment to the CEO role and the Board, making this an executive appointment event.
View raw filing on EDGAR →Three independent directors—Rakhi Kumar, Brad Middlekauff, and Patrick Crutcher—were appointed to the board in connection with the IPO on May 18, 2026, and concurrently appointed to key board committees including Audit, Compensation, and Nominating and Corporate Governance.
View raw filing on EDGAR →The filing discloses the appointment of Zhong Li as an independent director effective May 18, 2026, with assignment to the Audit, Compensation, and Nominating and Corporate Governance Committees. While the filing also mentions the concurrent resignation of Ningrong Liu, the substantive disclosure centers on the appointment of a new director with detailed background information highlighting his 20+ years of experience in finance, regulation, and technology across multiple jurisdictions and institutions. For a SPAC, director appointments are material governance events affecting investor assessment of board composition and oversight capability.
View raw filing on EDGAR →Ronald Kisling was appointed as Chief Financial Officer effective May 20, 2026, with compensation terms including a $500,000 base salary, $200,000 signing bonus, 150,000 restricted stock units, and 30,000 performance stock units. John Frederick's retirement as CFO is also disclosed in connection with this transition.
View raw filing on EDGAR →The filing discloses both a director departure (Lewis Titterton's retirement on May 15, 2026) and a director appointment (Anthony Bowers appointed on May 19, 2026). While both events are present, the prose centers on the appointment as the principal action—Bowers was "unanimously appointed" to fill the vacancy and assigned to key committees (Audit and Compensation). The appointment of a director to sensitive committees is material to investors assessing board composition and governance, making this an exec_appointment event.
View raw filing on EDGAR →The filing discloses the appointment of Ronen Tanami as Chief Operating Officer on May 13, 2026, which is the principal action reported. While the Item 5.02 disclosure also includes compensatory details (a 40,000-share option grant), the core event is the executive appointment. The appointment of a COO is material to investors as it reflects a significant change in the company's management structure.
View raw filing on EDGAR →The filing discloses the Board's appointment of Taehoon Kim, the current CEO, to the additional roles of Principal Financial Officer and Principal Accounting Officer, effective immediately on May 18, 2026. This is a material executive appointment that consolidates critical financial and accounting oversight functions under the CEO following the previously announced resignation of CFO Juhyon Shin. The appointment of a principal financial officer is a material event affecting investor assessment of the company's financial governance and leadership structure.
View raw filing on EDGAR →Teresa Chia was appointed to the Board of Directors effective May 22, 2026, as an independent director and Audit Committee member, filling a vacancy created by Jennifer Ceran's non-re-election.
View raw filing on EDGAR →Peggy S. Rebstock was appointed by the Board on May 20, 2026, to serve as Vice President, Chief Accounting Officer and Controller, effective May 21, 2026, with a base salary of $320,000, 50% target cash incentive, and equity awards.
View raw filing on EDGAR →The filing discloses the appointment of Alfred T. Rogers, Jr. as President, Chief Executive Officer, and Board member of BayFirst Financial Corp., effective May 14, 2026, following Federal Reserve approval. This is a principal executive officer appointment at a financial institution, which is material to investors assessing company leadership and governance.
View raw filing on EDGAR →Pamela Smith was appointed as Interim Chief Financial Officer effective May 20, 2026, replacing Michelle Hook in both principal financial officer and principal accounting officer roles.
View raw filing on EDGAR →Genvor Inc appointed Donald Kalkofen as Chief Financial Officer effective May 18, 2026. The appointment includes compensatory arrangements comprising monthly cash compensation of $6,250 plus $7,750 deferred, and stock options for 575,000 shares. Kalkofen brings extensive experience with IPOs and capital markets transactions relevant to the company's development stage.
View raw filing on EDGAR →Kirk Oliver was appointed to the Board of Directors and two Board committees effective May 21, 2026, increasing the Board size from five to six directors. Oliver brings substantial executive experience as CFO of publicly traded energy companies (Equitrans, UGI Corporation) and will receive standard non-employee director compensation including equity grants.
View raw filing on EDGAR →Daniel L. Karpel was appointed Chief Financial Officer effective immediately on May 20, 2026, transitioning from interim CFO status. While the disclosure includes compensatory details (base salary of $550,000, equity awards totaling $1.285 million, and severance terms), the principal disclosed action is the appointment of an officer to a key executive role. The appointment of a CFO is material to investors as it affects the registrant's financial leadership and governance.
View raw filing on EDGAR →CONMED appointed two non-employee directors, Celine Martin and Jeff Mirviss, effective July 1, 2026, and appointed Kimberly Lockwood as Interim Corporate Controller and Interim Principal Accounting Officer effective June 1, 2026.
View raw filing on EDGAR →The disclosure centers on the Board's election of Douglas Recker as a director effective immediately on May 14, 2026. While Recker was already serving as CEO (since April 1, 2026) and President (since September 2025), the principal action disclosed in this Item 5.02 filing is his appointment to the Board. This is a material executive appointment that would affect investor assessment of the company's governance and leadership structure.
View raw filing on EDGAR →Sally Diffley was appointed Chief Financial Officer of Morgan Stanley Investment Management Inc., the delegated sponsor of the Trust, on May 14, 2026. This is a material executive appointment to a key financial leadership position at the entity responsible for managing the Trust's operations. The disclosure also notes the concurrent resignation of her predecessor, Rohit Goenka, but the principal action disclosed is Diffley's appointment to the CFO role.
View raw filing on EDGAR →The filing discloses the promotion of two executives—Tamara S. Johnson to Vice President, California Operations and Gregory D. Shimansky to Vice President, Rates and Regulatory Affairs—effective July 1, 2026. These are material appointments to senior officer positions at a regulated utility company where operational and regulatory leadership are critical to investor assessment.
View raw filing on EDGAR →Charles Fitzgerald was appointed to the Board of Directors of Chiron Real Estate Inc., effective May 20, 2026. The appointment was disclosed in both Item 5.02 and Item 7.01 (Regulation FD Disclosure via press release), with details regarding his background, committee assignments, and independence determination.
View raw filing on EDGAR →The filing discloses two executive appointments: (1) Brian LaRose, the CFO, was appointed principal accounting officer on May 15, 2026, succeeding Leah Putnam; and (2) Tamara Ward was appointed as a director and Chair of the Compensation Committee on the same date. While both are appointments, the principal accounting officer role is a named executive officer position under Item 5.02, making this a material executive appointment. The appointment of a director with committee leadership responsibilities is also material to investors assessing governance and financial oversight.
View raw filing on EDGAR →Robert D. Wright was appointed as President and Chief Executive Officer of Wendy's, effective May 21, 2026, and elected to the Board of Directors. The appointment includes compensatory arrangements with a base salary of $1 million, a performance-based bonus target of 175%, and LTIP awards totaling $5.5 million.
View raw filing on EDGAR →Scott Hortenstine is being designated as Sabre's principal accounting officer and Vice President and Controller, effective July 1, 2026. This is a material executive appointment to a key financial reporting role. While the disclosure also notes that Jami Kindle will continue as principal accounting officer through June 30, 2026, the principal disclosed action is Hortenstine's appointment to this critical position, making this an exec_appointment event.
View raw filing on EDGAR →Rehan Jaffer will be appointed to Six Flags' board of directors as a Class III director following the May 26, 2026 Annual Meeting, replacing departing director Arik Ruchim. The appointment is part of a Cooperation Agreement with H Partners, a significant long-term investor, and includes assignment to the Audit and Finance Committee, voting agreements, and standstill provisions affecting shareholder governance.
View raw filing on EDGAR →Andrew Clipsham was appointed as Interim Chief Financial Officer, effective upon Weinswig's departure.
View raw filing on EDGAR →The filing discloses the appointment of Luke Wood to the board of directors following the board's approval to increase its size from twelve to thirteen members. While the section also mentions compensation under the Non-Employee Director Compensation Policy, the principal disclosed action is the appointment itself. The appointment of an experienced executive (former President of Beats by Dr. Dre and Apple VP) to the board is material to investors assessing governance and board composition.
View raw filing on EDGAR →The filing discloses the appointment of John Hazlett as Chief Financial Officer effective May 20, 2026, with detailed background, qualifications, and employment terms including base salary of $216,000 and performance incentives. While the section also mentions the departure of the prior CFO John Ferry, the principal disclosed action centers on the new appointment and its terms, making exec_appointment the most salient classification.
View raw filing on EDGAR →Michael Tarnok was appointed as a Class II director and Kevin Cameron (the CEO) was appointed as a Class III director; David Landskowsky resigned from the board. The board size increased from four to five members.
View raw filing on EDGAR →The filing discloses the appointment of David R. Wells as Chief Financial Officer and Board member effective May 18, 2026, approved by unanimous written consent. While the section also covers Tariq Rahim's resignation from the Board and transition from CFO, the principal disclosed action centers on the appointment of a new CFO and director, which is material to investors assessing the company's financial leadership and governance.
View raw filing on EDGAR →The filing discloses the appointment of four new directors to the Board effective April 1, 2026: Elyssa Jacob Campbell, James C. Jones, Anthony Porter, and David Mauer. The disclosure provides detailed background on each appointee's professional experience and qualifications. This is a material governance event affecting board composition at a public company.
View raw filing on EDGAR →Ms. Elizabeth Magennis was appointed President of ConnectOne Bancorp at the annual reorganizational meeting, representing a promotion from Executive Vice President.
View raw filing on EDGAR →The filing discloses the appointment of Gregg Hemphill as a director of Newton Golf Company, Inc., effective May 19, 2026, upon recommendation of the Nominating and Corporate Governance Committee. The Board also appointed him to serve on three committees (Audit, Compensation, and Nominating). While the disclosure includes compensation details (annual cash retainer of $30,000 and RSU grants), the principal disclosed action is the director appointment itself, making this an exec_appointment event. Director appointments are material to investors as they affect board composition and governance.
View raw filing on EDGAR →The Board approved the appointment of Massimo Andolina as Group Chief Financial Officer, effective August 1, 2026, succeeding Emmanuel Babeau. This C-suite appointment is material to investors' assessment of the company's financial leadership and governance.
View raw filing on EDGAR →The Board elected Adam Demuyakor to the Board effective June 1, 2026, and assigned him to three Board committees (Compensation, Risk Oversight, and Corporate Governance). This director appointment was disclosed via press release on May 20, 2026.
View raw filing on EDGAR →The filing centers on the Board's approval on May 17, 2026 of Robert Alex Walsh's appointment as Chief Financial Officer, effective July 13, 2026, succeeding Gaetano Franceschi. While the section also discloses Franceschi's departure and Walsh's compensation package (base salary $450,000, target incentive $450,000, RSU and PSU awards), the principal disclosed action is the appointment of a new CFO—a principal officer role material to investors. The compensation details are ancillary to the appointment itself.
View raw filing on EDGAR →The filing discloses both a director departure (Andres Small's resignation) and a director appointment (Rachael Wagner's appointment to the Board as a Class III director). While both events occurred on the same date, the appointment is the principal forward-looking action and receives substantive disclosure (independence determination, compensation terms, board composition post-appointment). The appointment of a new independent director to a 12-member board is material to investors assessing board composition and governance.
View raw filing on EDGAR →Ali El-Haj was appointed as President, Chief Executive Officer, and Director of Rogers Corporation, effective immediately on May 19, 2026, transitioning from Interim President and CEO to permanent roles. The appointment includes compensation details including a base salary of $750,000, target incentive of 100% of base, and a $5,000,000 long-term equity grant.
View raw filing on EDGAR →The filing discloses the appointment of Carrie Anderson as Executive Vice President and Chief Financial Officer effective July 1, 2026, succeeding retiring Charles T. Lauber. While the section also mentions Lauber's retirement, the principal disclosed action centers on Anderson's appointment to a C-suite role, supported by detailed background, compensation terms ($1.5M RSU award), and benefit arrangements. This is a material executive appointment at a major industrial company.
View raw filing on EDGAR →The filing discloses the appointment of Thomas Dittrich as Executive Vice President and Chief Financial Officer effective September 1, 2026, along with detailed compensation arrangements including base salary (CHF 1,070,000), equity grants (CHF 4,500,000 target), sign-on RSU award (CHF 4,700,000), and retention bonus (CHF 5,800,000). While the section also mentions Peter Griffith's retirement, the substantive focus and length of disclosure centers on Dittrich's appointment and his comprehensive compensation package, making this primarily an exec_appointment event. The appointment of a CFO is material to investors as it affects the company's financial leadership and governance.
View raw filing on EDGAR →The filing discloses both a director retirement (Gary Lehman) and a director appointment (Paul Fultz). While both events are mentioned, the appointment is the principal forward-looking action: Fultz was appointed to fill the vacancy and will serve on the Audit Committee. The explicit statement that Lehman's retirement "is not the result of any disagreement" suggests a routine transition, making the appointment the more salient event. Director changes are material to investors assessing board composition and governance.
View raw filing on EDGAR →Scott R. Ward was elected as a director of Merit Medical Systems Inc., as announced via press release on Form 8-K.
View raw filing on EDGAR →The filing discloses the appointment of Keith D. Rose, M.D. as Chief Medical Officer, effective May 1, 2026. This is a material executive appointment to a senior leadership position. Dr. Rose's extensive background in medical affairs and clinical leadership across major pharmaceutical companies (Novocure, Ipsen, Jazz Pharmaceuticals, Indivior) demonstrates the significance of this hire to the Company's medical and clinical strategy.
View raw filing on EDGAR →The filing discloses multiple executive appointments on May 18, 2026: Dr. Miralles as President and Head of R&D (with $600,000 base salary, 45% bonus target, and substantial equity grants of 232,500 options and 77,500 RSUs), and Dr. Aslan as principal financial and accounting officer. While the section also includes departures (Dr. Miralles from the Board, Dr. Aslan from President, and Thad Huston as CFO), the principal disclosed actions center on the appointments of these executives to new roles with defined compensation packages, making exec_appointment the most salient classification.
View raw filing on EDGAR →The filing discloses the appointment of Jeff Newgard as President and Chief Executive Officer of GBank effective June 8, 2026, with detailed compensation terms including a $500,000 base salary, $100,000 sign-on bonus, equity grants of 20,000 restricted shares, and relocation assistance. While the section also mentions A. Lee Finley's resignation as a director, the principal and substantive disclosure centers on the executive appointment with comprehensive employment agreement details. This is a material executive appointment that would affect investor assessment of company leadership.
View raw filing on EDGAR →The filing discloses the appointment of Andrea Brimmer to the Board of Directors of Primo Brands Corporation, effective May 15, 2026, to fill a newly created vacancy. While the Board size increase is administrative, the principal disclosed action is the appointment of a director with significant executive experience (Chief Marketing and Public Relations Officer at Ally Financial Inc. since 2015) and board service at other public companies. This is a material corporate governance event affecting the composition of the Board.
View raw filing on EDGAR →EagleRock Land, LLC appointed six new directors on May 13, 2026: Richard H. Coats as chairman and Raj Kumar, Jeff S. Lott, James C. Nelson, Stephanie Reed, and Michael Wallace as board members, expanding the Board from one director to seven members in connection with the public offering.
View raw filing on EDGAR →Michael W. Bonney was appointed as Chair of the Board effective May 16, 2026. Mr. Bonney brings extensive executive and board leadership experience from prior CEO roles at Cubist Pharmaceuticals and Kaleido Biosciences, and this senior governance appointment is material to investors assessing the company's strategic direction.
View raw filing on EDGAR →The disclosure centers on the appointment of Andrew Jhawar to Sprouts Farmers Market's Board of Directors as a Class III director effective May 19, 2026, with assignment to the Audit Committee. While the section also mentions Doug Rauch's retirement, the principal action disclosed is Jhawar's appointment to the board. Board composition changes are material to investors as they affect governance and oversight.
View raw filing on EDGAR →Vistagen appointed Angel S. Angelov, M.D., MBA as Chief Medical Officer effective May 18, 2026, with a base salary of $425,000, signing bonus, equity grants including 150,000 stock options, and bonus eligibility.
View raw filing on EDGAR →